Abstract: Src kinase plays an important role in integrin signaling by regulating cytoskeletal organization and cell remodeling. Previous in vivo studies have revealed that the SH3 domain of c-Src kinase directly associates with the C-terminus of b 3 integrin cytoplasmic tail. Here, we explore this binding interface with a combination of different spectroscopic and computational methods. Chemical shift mapping, PRE, transferred NOE and CD data were used to obtain a docked model of the complex. This model suggests a different binding mode from the one proposed through previous studies wherein, the C-terminal end of b3 spans the region in between the RT and n-Src loops of SH3 domain. Furthermore, we show that tyrosine phosphorylation of b 3 prevents this interaction, supporting the notion of a constitutive interaction between b 3 integrin and Src kinase.
Introduction
Integrins comprise a large family of bidirectional signaling receptors that tether extracellular matrix to the cytoskeleton and regulate cellular behavior via classical signaling pathways. 1 These major cell surface receptors mediate cell adhesion, migration, proliferation, differentiation, and programmed cell death through "inside-out" and "outside-in" signaling events. Over the last decade, substantial progress has been made in structural characterization of integrins within these signaling cascades. Inside-out signaling is initiated by the separation of heterodimeric cytoplasmic tails causing an overall conformational change that propagates across the membrane to the extra-cellular domain of the receptor. 2 In contrast, ligand binding to the extracellular domain leads to conformational changes across the receptor transducing the signal through the membrane, to the cytoplasm further leading to a series of downstream signaling events referred to as outside-in signaling. 3 Major platelet integrin a IIb b 3 , an archetypical representative of the class, regulates platelet aggregation and serves as a molecular scaffold interacting with various extracellular and intracellular binding partners. Shattil and co-workers 4, 5 have shown that outside-in signaling in platelets is mediated by a direct interaction of carboxyl terminus b 3 integrin with Src kinase.
In humans, c-Src, a founding member of Src family non-receptor tyrosine kinases (SFKs), is a 60 kDa membrane anchoring cytosolic protein. The role of c-Src (hereafter referred to as Src) has been implicated in various cellular functions including cell division, motility, and cell survival. It is abundantly expressed in platelets and is vital to many vascular processes. 6 Src is a multi-domain protein composed of: (i) an N-terminal myristoylation site, (ii) SH4 domain, (iii) SH3 domain, (iv) SH2 scaffold domain, and (v) catalytic kinase domain, followed by a tyrosine (Y 527 ) containing C-terminal regulatory sequence. In resting cells, intra-and inter-molecular interactions mediated by Src SH2 domain and Csk (C-terminal Src kinase) respectively, maintain Src kinase in its autoinhibited state, characterized by the phosphorylation of its Tyr
527
. This inactive form of Src is proposed to bind the resting b 3 integrin cytoplasmic tail through its SH3 domain. 7 integrin interaction with Src should help in the comprehension of its outside-in signaling events. This is particularly true for platelets, osteoclasts, and endothelial cells, where both proteins are found in abundance. 4, 7 Src SH3 domain, recognized as the key integrin binding site, 5 has been extensively studied and structurally characterized in both free and ligand bound states (PDB: 1RLQ, 1QWF, 1NLP). It consists of two antiparallel b sheets positioned at right angles to one another. The b strands are linked via RT loop, n-Src loop, distal loop, and a short 3 10 -helix. 8, 9 In general, SH3 domains are known to favor peptides bearing a PxxP motif. 10 The PxxP motif adopts a polyproline type II (PPII) helix and binds between the RT loop and n-Src loop. The selectivity of these peptides is further enhanced by basic residues, arginines or lysines, which flank the core motif. In addition, other mechanisms may contribute towards the specificity of this interaction with the SH3 domain. 11 Although two classes of peptides, class I-(R/K)xxPxxP and class II-PxxPx(R/ K), [10] [11] [12] are considered as canonical SH3 binding targets, accumulating evidence suggests that SH3 can also recognize non-PxxP motifs. 10, [13] [14] [15] The exact molecular details of such recognition still remain unclear. However, some non-PxxP peptides have been shown to occupy the same interface as PxxP motifs. 16 In this article, we present the NMR data and a docked model of SH3 with cytoplasmic integrin b 3 . We also show that the C-terminal RGT motif of b 3 adopts a partial PPII type helix facilitating its interaction with the RT and n-Src loops of SH3 in an orientation opposite to that obtained from X-ray studies. 17 Finally, NMR titration studies demonstrate no interaction with the phosphorylated b 3 , supporting the idea of a constitutive interaction between non-stimulated/resting (non-phosphorylated) b 3 integrin and the SH3 domain of Src kinase. Since no chemical shift differences were found in either case, even at a high molar ratio of 1 to 5 (Supporting Information Fig. S1 ), we concluded that tyrosine phosphorylation prevents SH3 from binding to b 3 . This finding is consistent with the previously suggested mechanism of constitutive interaction of Src with unactivated/resting, non-phosphorylated integrin b 3 .
Results

Previous
5
We additionally carried out Paramagnetic Relaxation Enhancement (PRE) experiments to ascertain the orientation of bound integrin. A paramagnetic spin label was attached to the b 3 mutant containing a cysteine residue added to its C-terminal end. The nitroxide radical from the spin label attenuates peak intensities of nearby residues allowing direct mapping of its location onto the binding surface. Since the label is attached next to the RGT motif, maximum attenuation is expected for SH3 residues adjacent to the ones involved in binding of this motif. To test whether the addition of a paramagnetic tag affected the interaction, we compared the spectra of SH3 in the presence of wild type b 3 CT and its tagged mutant (Supporting Information Fig.  S2 ). Since no significant differences were observed we proceeded with the PRE analysis to study this interaction.
15 N-HSQC spectra were collected at an from the SH3 domain in close proximity to the nitric oxide from the tag, allowed us to reliably predict the orientation of the RGT motif within the SH3 binding interface.
To further define the molecular details of the complex, in particular, the conformation of integrin C-terminus bound to the SH3 domain, we employed transferred NOE (trNOE). This method is best suited to study weakly associating systems comprising of small ligands bound to large molecules. NOESY spectrum of b 3 heptapeptide, collected in the presence of GST-fused SH3 at an optimized peptide to protein molar ratio of 200 to 1, demonstrates the additional peaks manifesting the binding [ Fig.  3(a) ]. These peaks were absent in the control experiment with GST alone. Although partial assignments for the bound heptapeptide were made, insufficient amount of distance restraints deterred us from obtaining the complete structure of the complex. As no medium-range NOEs characteristic for a-helical secondary structure were observed, we speculate that upon binding the peptide exists as an ensemble of random coil and extended conformers. The secondary structure of the heptapeptide was further probed by circular dichroism (CD). The spectra showed a negative band at 197 nm and a positive band at 229 nm [ Fig. 3(b) ], reflecting the presence of a left handed PPII helix. Molar ellipticities per residue for these two bands are somewhat weaker for b 3 heptapeptide when compared to the values reported in literature for peptides adopting a polyproline type II helix conformation. 20, 21 This suggests that b 3 heptapeptide might adopt a partial PPII type helical conformation.
Various models of b 3 heptapeptide were generated (with or without C-terminal paramagnetic label attached) using the Haddock (High Ambiguity data driven protein-protein DOCKing) web server 22, 23 to investigate the binding of b 3 heptapeptide to SH3 domain (PDB: 1SRL). The ambiguous interaction restraints (AIRs) were defined by NMR titration and PRE experiments with the starting conformation of the heptapeptide consistent with our trNOE and CD data. Cluster analysis of the resulting 200 waterrefined models reveals 72% (with the paramagnetic tag) and 69% (without tag) of these models belong to a single cluster. Both clusters accommodate very similar binding interfaces as shown in the inset of Supporting Information Figure S2 . The backbone root mean square deviation (RMSD) from the lowest energy model for the conformers from the cluster with tag is 1.1 Å , while for the conformers from the cluster without tag is 1.3 Å .
Discussion
The initial events in b 3 integrin outside-in signaling rely on its association with the SH3 domain of Src kinase. We have deduced the molecular details of this interaction using NMR. Chemical shifts mapping experiments depict the C-terminus of b 3 located between the RT and n-Src loops of SH3 domain, with Y 131 from the b4 strand serving as a bridge between the two. As per our PRE results, the RGT motif binds to the pocket formed by the n-Src loop. The preceding NITY motif makes occasional intermediate contacts with the RT loop rendering its conformational heterogeneity. The experimental data allowed us to obtain a reliable docked model of the complex using the HADDOCK web server. We are certain that our docking model provides a more accurate representation of the binding interface [ Fig. 4(c) ] than the recent X-ray model (PDB: 4HXJ) containing the RGT tri-peptide 17 [ Fig. 4(d) ] for the following reasons: (i) We have used the longer construct, full length b 3 cytoplasmic tail, in addition to the heptapeptide. According to our model, the RGT motif binds to n-Src loop while the remainder of the b 3 tail extends into the RT loop. The "fishing hook" arrangement presented in the X-ray structure which places integrin on top of SH3, would not explain the conformational exchange in the RT loop observed in our titration experiments. Moreover, our CD data shows that the heptapeptide has a partial PPII helix, a characteristic feature of SH3 binding ligands which tend to interact between the RT and the n-Src loops.
(ii) We have attached the paramagnetic tag to the C-terminal end of RGT sequence, which allowed us to orient the RGT motif unambiguously with respect to its SH3 binding pocket. If the orientation were to be as per the X-ray structure, we would have seen the PRE effect opposite to the current site on SH3's surface. Moreover, the weak electron density map, used to fit the small RGT tri-peptide, could easily lead to an ambiguous orientation. This ambiguity is further accentuated by the following two observations form the X-ray structure: the average B-factor for RGT is 67 Å 2 , much higher than that of the SH3 domain itself (13. ensemble, while in the X-ray model this crucial arginine exhibits predominantly hydrophobic contacts with a single backbone amide hydrogen bonded to D 117 . (iv) Furthermore, the electrostatic surface potential of SH3, presented for the apo-domain in Supporting Information Figure S3 (a) and for our model in Supporting Information Figure S3 (c) provides a more plausible binding opportunity that is driven by polar interactions between the negatively charged groove on the SH3 surface and positively charged side-chain of R 760 , proving critical for the complex formation 17 and shown to enhance selectivity (as an R/Kxx or xR/K addition) when linked to PxxP, the canonical SH3 binding motif. 11 The surface potential for SH3 domain calculated based upon the coordinates from the X-ray complex (PDB: 4HXJ), presented in Supporting Information Figure  S3 (b), makes it electrostatically unfavorable to place the negatively charged carboxyl end of the peptide into the negatively charged groove on SH3. The X-ray structure of the inactive Src kinase (PDB: 2SRC) shows the linker connecting the SH2 and the kinase domains in close proximity to the RT and n-Src loops of SH3 domain. 24 The question remains whether b 3 binds to Src kinase in its inactive closed form in the presence of the linker, and, if so, how does the linker affects its affinity for Src kinase. Or, alternatively, b 3 might bind to the open form, replacing the linker, thus preventing Src kinase from becoming inactive and maintaining a small population of active kinase partially poised to start the activation process induced by integrin microclustering. In light of the proposed mechanism of outside-in signaling, 7 where some integrin b 3 molecules are primed for activation of Src kinase, the weak binding as observed from our trNOE experiments seem pertinent. In addition, we have further investigated whether SH3 domain binds to the phosphorylated b 3 and found no interaction, suggesting that Src can be associated with integrin through its SH3 domain only in the resting non-phosphorylated state of the receptor. We believe that this weak but constitutive interaction would keep Src tethered to the integrin and consequently bring two or more Src kinases to close proximity upon integrin activation via clustering. 5 This, in turn, would aid in trans-activation of the kinase through auto-phosphorylation of Y 418 in the Src activation loop.
In conclusion, our chemical shifts mapping data in concert with PRE, trNOE and CD studies have confirmed the RGT 762 motif of b 3 integrin as the binding site for Src kinase. We have used these datas to generate a reliable model of the complex through docking. Furthermore, we have shown that tyrosine phosphorylation of b 3 cytoplasmic tail prevents it from binding to SH3, corroborating the reports of a constitutive interaction between resting integrin b 3 and Src kinase. (MPCb 3 and BPb 3 respectively) were synthesized chemically (Genemed Synthesis; NEO-peptides).
Expression and purification
Cloning, expression, and purification of cytosolic b 3 was done as described elsewhere. 2 The human Src SH3 (residue 80-144) in pGEX-4T1 vector was expressed in BL21(DE3) after induction with 1 mM IPTG. To produce 15 N isotopically labeled Src SH3, cells were grown in M9 minimal media containing 15 NH 4 Cl. GST-tagged SH3 was purified in PBS buffer (140 mM NaCl, 27 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.2) using Pierce Glutathione Agarose resin (Thermo Scientific). SH3 was eluted by either cleavage with thrombin or by using 10 mM glutathione in PBS buffer. The eluate was further purified through HiLoad 16/60 Superdex 75 column (GE Healthcare) equilibrated with PBS buffer.
NMR spectroscopy
All experiments were performed at 25 C using 0.1 mM protein samples (unless otherwise mentioned), on 600 MHz magnet (Agilent) equipped with inverse-triple resonance cold probe.
15 N-HSQC titration: Concentrated stock solutions of b 3 peptides were prepared in the same buffer as Src and added to the 15 N-labeled SH3 domain at different peptide to protein molar ratios. Each data point was also reverse titrated beginning from the saturated conditions for the peptides. Experiments were performed at pH 5.8. The SH3 spectra at different pH were collected as a negative control. All the spectra were collected with 2048 complex data points in t2 and 128 increments in t1 dimensions and zero filled to 2048 3 1024 data points. The spectra were processed with NMRPipe 25 and analyzed by CCPN software suite. 26 Chemical shift assignments for SH3 domain were obtained from BMRB database entry 3433. 9 The shifts were adjusted to match our experimental conditions. Transferred NOE: b 3 heptapeptide was mixed with GST-fused SH3 at pH 6.5. Different peptide to SH3 ratios were investigated to find the optimal one for NOE transfer in two-dimensional proton NOESY experiments with the mixing time of 400 ms. A negative control with just the GST tag was performed under the same conditions at an optimized heptapeptide to GST ratio of 200 to 1. Partial 1 H resonance assignments for the heptapeptide were obtained by collecting TOCSY (mixing time of 70 ms) and NOESY (mixing time of 400 ms) spectra. Paramagnetic Labeling: In order to introduce a spin label, b 3 mutant was constructed with an additional cysteine residue after the terminal YRGT sequence using QuikChange site-directed mutagenesis kit (Agilent). Prior to the reaction, the mutant was reduced by 1 mM TCEP, which was subsequently removed by washing on a PD-10 column (GE Healthcare). The reduced b 3 mutant was allowed to react overnight with either an excess of cysteine specific spin label, 3-maleimido-PROXYL, hereafter referred to as mProxyl (Sigma-Aldrich), or 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) methanethiosulfonate, hereafter referred to as MTSL (Alexis Biochemicals). The reactions were performed at room temperature at a pH of 7.0. The unreacted spin label was separated from the tagged mutant by reverse phase HPLC on PROTO C4 column (The Nest Group). Attachment of the tag was confirmed through mass spectrometry. 15 N-HSQC spectrum of SH3 in the presence of tagged b 3 mutant (as well as a control with untagged mutant) was collected under the same conditions as used for wild type b 3 titrations.
Circular dichroism
CD experiments were done on PiStar 180 Spectrometer (Applied Photophysics, UK). The sample was prepared by dissolving b 3 heptapeptide in 20 mM phosphate buffer at pH 6.5. Spectrum was collected in the far UV range at 25 C with a step resolution of 0.5 nm, bandwidth of 3.0 nm and data averaging of 30 s/point.
Electrostatic potentials mapping
The potential files used for mapping were prepared from the respective PDB files by Adaptive PoissonBoltzmann Solver (APBS), 27 a program that maps the electrostatic potential energy based on PoissonBoltzmann equation. The resultant (.pqr and.in) files from pdb2pqr webserver served as input for APBS calculations. APBS webserver as well as Chimera's APBS built-in tool were used to prepare the electrostatic potential maps which further rendered the electrostatic surface using Chimera's Electrostatic Surface Coloring tool. Alternatively the surface potential was also directly mapped using Coulombic surface mapping.
